Tasos Konidaris's Net Worth

$2.44 Million

Estimate Recalculated May 28, 2024 03:42PM EST

Who is Tasos Konidaris?

Tasos Konidaris has an estimated net worth of $2.44 Million. This is based on reported shares across multiple companies, which include Amneal Pharmaceuticals, Inc., Kadmon Holdings, Inc., DELCATH SYSTEMS, INC., PERNIX THERAPEUTICS HOLDINGS, INC., and DUN & BRADSTREET CORP/NW.

SEC CIK

Tasos Konidaris's CIK is 0001320982

Past Insider Trading and Trends

2007 was Tasos Konidaris's most active year for acquiring shares with 6 total transactions. Tasos Konidaris's most active month to acquire stocks was the month of February. 2021 was Tasos Konidaris's most active year for disposing of shares, totalling 6 transactions. Tasos Konidaris's most active month to dispose stocks was the month of February. 2019 saw Tasos Konidaris paying a total of $229,000.00 for 100,000 shares, this is the most they've acquired in one year. In 2021 Tasos Konidaris cashed out on 506,129 shares for a total of $2,502,732.80, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Amneal Pharmaceuticals, Inc. (AMRX) Snapshot price: $5.3683

Executive Vice President & CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+12.10%
56.93K
$5.31
-$163,494.90
527.32K
Mar 12
Form 4
+23.51%
89.55K
$5.47
-$269,561.60
470.39K
Mar 1 - Mar 4
Form 4
+29.93%
87.72K
380.84K
Mar 12
Form 4
+18.27%
45.29K
293.12K
Mar 3
Form 4
+17.10%
36.2K
247.83K
Mar 1
Form 4
+70.79%
87.72K
211.63K
Mar 12
Form 4
+41.26%
36.2K
123.92K
Mar 1 - Mar 3
Form 4
87.72K
87.72K
Mar 12
Form 4
0
0
Mar 1
Form 4
0
0
Mar 12
Form 3
0
0
No matching records found

Kadmon Holdings, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
Nov 9
Form 4
0
0
May 12
Form 4
0
0
May 13
Form 4
0
0
May 15
Form 4
0
0
Jul 27
Form 4
0
0
Jun 29
Form 3
0
0
No matching records found

DELCATH SYSTEMS, INC. (DCTH) Snapshot price: $4.645

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+466.34%
9.62K
11.68K
Jul 7
Form 4
33K
33K
Jun 5
Form 4
0
0
Jul 6
Form 3
0
0
No matching records found

PERNIX THERAPEUTICS HOLDINGS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
0
0
May 26
Form 4
0
0
Aug 14
Form 4
0
0
Apr 25
Form 3
0
0
No matching records found

DUN & BRADSTREET CORP/NW No price found

SVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+0.06%
11.29
$79.01
$855.68
18.7K
Mar 16
Form 4
-2.33%
-446.00
$80.11
-$35,729.06
18.69K
Mar 4
Form 4
+33.43%
4.79K
$80.45
-$22,043.30
19.14K
Mar 1
Form 4
-4.86%
-732.00
$83.57
-$61,169.58
14.34K
Feb 22
Form 4
+0.11%
17.26
$79.57
$1,373.38
15.07K
Dec 13
Form 4
+0.13%
19.9
$68.66
$1,366.41
15.06K
Sep 15
Form 4
+0.12%
18.58
$73.19
$1,359.90
15.04K
Jun 16
Form 4
+0.12%
18.45
$73.36
$1,353.45
15.02K
Mar 18
Form 4
-1.94%
-297.00
$69.96
-$20,778.12
15K
Mar 4
Form 4
+33.83%
3.87K
15.3K
Mar 1
Form 4
-8.29%
-1.03K
$70.90
-$73,236.55
11.43K
Feb 22 - Feb 23
Form 4
0
0
Feb 11
Form 4
+50.65%
4.19K
12.46K
Mar 4
Form 4
-12.35%
-1.17K
$73.12
-$85,263.27
8.27K
Feb 22 - Feb 24
Form 4
0
0
Feb 19
Form 4
0
0
Feb 4
Form 4
+57.92%
3.46K
$90.80
-$47,485.78
9.44K
Feb 22 - Feb 24
Form 4
0
0
Feb 6
Form 4
+0.26%
0.02
$98.05
$1.67
6.63
Sep 17
Form 4
+0.24%
0.02
$100.17
$1.60
6.61
Jun 15
Form 4
+0.27%
0.02
$90.43
$1.63
6.61
Mar 29
Form 4
0
0
Mar 1
Form 4
+113.62%
3.18K
5.98K
Feb 23
Form 4
0
0
Feb 8
Form 4
2.8K
2.8K
Feb 24
Form 4
0
0
Feb 9
Form 3
0
0
No matching records found